163 related articles for article (PubMed ID: 5215559)
21. Phase II study of chlorozotocin in advanced breast cancer.
Edmonson JH; Green SJ; Ingle JN; Ahmann DL; Disel HF; Creagan ET
Cancer Treat Rep; 1981; 65(5-6):537-8. PubMed ID: 6453648
[No Abstract] [Full Text] [Related]
22. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
Brunner KW
Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
[No Abstract] [Full Text] [Related]
23. Advances in chemotherapy options for metastatic breast cancer: introduction of epothilones.
McGee L
ONS Connect; 2007; 22(8 Suppl):29-30. PubMed ID: 17824553
[No Abstract] [Full Text] [Related]
24. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
Awada A
Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
[TBL] [Abstract][Full Text] [Related]
25. [Experiences with Drostanolone-Propionate (Masterid) in metastasizing breast carcinoma].
Drings P; Fritsch H; Schmidt-Hermes HJ
Ther Ggw; 1972 Apr; 111(4):547-8 passim. PubMed ID: 5029717
[No Abstract] [Full Text] [Related]
26. [The principle of chemotherapy in relapse and metastatic breast cancer].
Breast Cancer Society Chinese Anti-Cancer Association
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):73-5. PubMed ID: 21418985
[No Abstract] [Full Text] [Related]
27. Phase II evaluation of vindesine in patients with advanced breast cancer.
Currie VE; Camacho F; Wittes R; Young C
Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
[No Abstract] [Full Text] [Related]
28. Relevance of the occult metastasis existing at the time of surgical intervention as a target for a chemotherapeutic treatment.
Peek U; Marx G; Greiner P; Seifart W; Tanneberger S
Arch Geschwulstforsch; 1978; 48(7):616-26. PubMed ID: 736742
[No Abstract] [Full Text] [Related]
29. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
[No Abstract] [Full Text] [Related]
30. Combination antimetabolite and alkylating agent chemotherapy in advanced breast carcinoma.
Greenspan EM
N Y State J Med; 1968 Mar; 68(6):780-6. PubMed ID: 4967021
[No Abstract] [Full Text] [Related]
31. [Chemotherapy after second-line chemotherapy for patients with advanced or metastatic breast cancer].
Ogasawara Y; Doihara H; Takahashi M; Kawasaki K; Taira N
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1713-6. PubMed ID: 18931574
[TBL] [Abstract][Full Text] [Related]
32. [Prevention of breast cancer recurrence--cytostatic agents].
Karrer K
Wien Klin Wochenschr; 1970 Jun; 82(25):465-7. PubMed ID: 5523880
[No Abstract] [Full Text] [Related]
33. [Therapy of metastasizing breast cancer].
Konrad RM; Ammedick U; Frings N
Med Welt; 1978 May; 29(18):742-5. PubMed ID: 651616
[No Abstract] [Full Text] [Related]
34. [Internal cancer therapy: cooperative clinical studies. Principles, organization and first results of the Swiss chemotherapy group].
Praxis; 1967 Dec; 56(50):1691-5. PubMed ID: 5632569
[No Abstract] [Full Text] [Related]
35. [Study of long surviving patients after treatment of thoracic metastases of breast neoplasms by combined hormone therapy and nonhormonal antineoplastic drug therapy from the onset].
Mannes P; Derriks R; Moens R
Lille Med; 1972 May; 17(5):762-4. PubMed ID: 4626798
[No Abstract] [Full Text] [Related]
36. Arterial regional chemotherapy of advanced breast cancer.
De Dycker RP; Timmermann J; Neumann RL; Wever H; Schindler AE
J Chemother; 1989 Jul; 1(4 Suppl):1193-5. PubMed ID: 16312830
[No Abstract] [Full Text] [Related]
37. Disseminated breast cancer. Current responses to cytotoxic drugs.
Sannan HJ; Ruby W; Garb S; Bograd M; Levine S
Rocky Mt Med J; 1978; 75(5):247-54. PubMed ID: 694337
[No Abstract] [Full Text] [Related]
38. [Combined chemo-radiotherapeutic treatment of breast neoplasms at the metastatis stage].
Agati G; Stoppa IM
J Radiol Electrol Med Nucl; 1967 Nov; 48(11):803-4. PubMed ID: 5591688
[No Abstract] [Full Text] [Related]
39. [Internal treatment of carcinoma with the cytostatic Proresid].
Schärtl W
Munch Med Wochenschr; 1966 Jan; 108(2):112-4. PubMed ID: 5341497
[No Abstract] [Full Text] [Related]
40. [Cytostatic therapy of metastatic breast cancer].
Mussa A; Dogliotti L; Musumeci SV; Linfanti CV; Alabiso O; Festa V; Giugno G; Sandrucci S; Benedetto G
Minerva Chir; 1980 Aug 15-31; 35(15-16):1195-225. PubMed ID: 7005745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
